BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 17717439)

  • 1. The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn.
    Jeschke MG; Finnerty CC; Suman OE; Kulp G; Mlcak RP; Herndon DN
    Ann Surg; 2007 Sep; 246(3):351-60; discussion 360-2. PubMed ID: 17717439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment.
    Przkora R; Jeschke MG; Barrow RE; Suman OE; Meyer WJ; Finnerty CC; Sanford AP; Lee J; Chinkes DL; Mlcak RP; Herndon DN
    Ann Surg; 2005 Sep; 242(3):384-9, discussion 390-1. PubMed ID: 16135924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy.
    Porro LJ; Herndon DN; Rodriguez NA; Jennings K; Klein GL; Mlcak RP; Meyer WJ; Lee JO; Suman OE; Finnerty CC
    J Am Coll Surg; 2012 Apr; 214(4):489-502; discussion 502-4. PubMed ID: 22463890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved net protein balance, lean mass, and gene expression changes with oxandrolone treatment in the severely burned.
    Wolf SE; Thomas SJ; Dasu MR; Ferrando AA; Chinkes DL; Wolfe RR; Herndon DN
    Ann Surg; 2003 Jun; 237(6):801-10; discussion 810-1. PubMed ID: 12796576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of oxandrolone and exercise on muscle mass and function in children with severe burns.
    Przkora R; Herndon DN; Suman OE
    Pediatrics; 2007 Jan; 119(1):e109-16. PubMed ID: 17130281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxandrolone in pediatric patients with severe thermal burn injury.
    Miller JT; Btaiche IF
    Ann Pharmacother; 2008 Sep; 42(9):1310-5. PubMed ID: 18682543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term effect of oxandrolone on hepatic acute phase proteins in severely burned children.
    Thomas S; Wolf SE; Murphy KD; Chinkes DL; Herndon DN
    J Trauma; 2004 Jan; 56(1):37-44. PubMed ID: 14749563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury.
    Demling RH; Orgill DP
    J Crit Care; 2000 Mar; 15(1):12-7. PubMed ID: 10757193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term oxandrolone administration in severely burned children.
    Murphy KD; Thomas S; Mlcak RP; Chinkes DL; Klein GL; Herndon DN
    Surgery; 2004 Aug; 136(2):219-24. PubMed ID: 15300183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxandrolone treatment in adults with severe thermal injury.
    Miller JT; Btaiche IF
    Pharmacotherapy; 2009 Feb; 29(2):213-26. PubMed ID: 19170590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxandrolone induced lean mass gain during recovery from severe burns is maintained after discontinuation of the anabolic steroid.
    Demling RH; DeSanti L
    Burns; 2003 Dec; 29(8):793-7. PubMed ID: 14636753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.
    Strawford A; Barbieri T; Van Loan M; Parks E; Catlin D; Barton N; Neese R; Christiansen M; King J; Hellerstein MK
    JAMA; 1999 Apr; 281(14):1282-90. PubMed ID: 10208143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rate of restoration of body weight after burn injury, using the anabolic agent oxandrolone, is not age dependent.
    Demling RH; DeSanti L
    Burns; 2001 Feb; 27(1):46-51. PubMed ID: 11164665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective randomized double-blind trial.
    Wolf SE; Edelman LS; Kemalyan N; Donison L; Cross J; Underwood M; Spence RJ; Noppenberger D; Palmieri TL; Greenhalgh DG; Lawless M; Voigt D; Edwards P; Warner P; Kagan R; Hatfield S; Jeng J; Crean D; Hunt J; Purdue G; Burris A; Cairns B; Kessler M; Klein RL; Baker R; Yowler C; Tutulo W; Foster K; Caruso D; Hildebrand B; Benjamin W; Villarreal C; Sanford AP; Saffle J
    J Burn Care Res; 2006; 27(2):131-9; discussion 140-1. PubMed ID: 16566555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxandrolone protects against the development of multiorgan failure, modulates the systemic inflammatory response and promotes wound healing during burn injury.
    Ahmad A; Herndon DN; Szabo C
    Burns; 2019 May; 45(3):671-681. PubMed ID: 31018913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with oxandrolone and the durability of effects in older men.
    Schroeder ET; Zheng L; Yarasheski KE; Qian D; Stewart Y; Flores C; Martinez C; Terk M; Sattler FR
    J Appl Physiol (1985); 2004 Mar; 96(3):1055-62. PubMed ID: 14578370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anabolic effects of oxandrolone after severe burn.
    Hart DW; Wolf SE; Ramzy PI; Chinkes DL; Beauford RB; Ferrando AA; Wolfe RR; Herndon DN
    Ann Surg; 2001 Apr; 233(4):556-64. PubMed ID: 11303139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age differences in inflammatory and hypermetabolic postburn responses.
    Jeschke MG; Norbury WB; Finnerty CC; Mlcak RP; Kulp GA; Branski LK; Gauglitz GG; Herndon B; Swick A; Herndon DN
    Pediatrics; 2008 Mar; 121(3):497-507. PubMed ID: 18310198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL.
    Reeves PT; Herndon DN; Tanksley JD; Jennings K; Klein GL; Mlcak RP; Clayton RP; Crites NN; Hays JP; Andersen C; Lee JO; Meyer W; Suman OE; Finnerty CC
    Shock; 2016 Apr; 45(4):367-74. PubMed ID: 26506070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burn size determines the inflammatory and hypermetabolic response.
    Jeschke MG; Mlcak RP; Finnerty CC; Norbury WB; Gauglitz GG; Kulp GA; Herndon DN
    Crit Care; 2007; 11(4):R90. PubMed ID: 17716366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.